Aiforia Technologies Plc, Company release, March 13, 2024 at 11:30 a.m. EET

Aiforia Technologies Plc Publishes its Board of Directors’ Report and Financial Statements for 2023

Aiforia Technologies Plc’s Board of Directors’ Report and Financial Statements for 2023 have been published. The Financial Statements consist of the consolidated as well as the parent company’s financial statements and auditor’s report.

The Board of Director’s Report and Financial Statements can be found attached to this release and are also available on the company’s website at https://investors.aiforia.com/en/reports_and_presentations.

Aiforia Technologies Plc

Board of Directors

Further inquiries

Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878 https://investors.aiforia.com/

Certified Adviser

UB Corporate Finance Oy, tel. +358 9 25 380 225

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com